30 related articles for article (PubMed ID: 21679919)
1. Induction of Kallikrein-Related Peptidase 13 and TET2/3 by Anticancer Drugs and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma After Preoperative Treatment.
Shimomura A; Hagiwara T; Yamada K; Yokoi C; Terayama M; Nohara K; Igari T; Kawamura YI
Ann Surg Oncol; 2024 Jan; 31(1):251-261. PubMed ID: 37798554
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers.
Chung J; Akter S; Han S; Shin Y; Choi TG; Kang I; Kim SS
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613569
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery.
Kong M; Shen J; Zhou C; Yang H; Chen B; Zhu C; Wang G
Ann Transl Med; 2020 Sep; 8(18):1129. PubMed ID: 33240978
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modeling.
Martin-Romano P; Solans BP; Cano D; Subtil JC; Chopitea A; Arbea L; Lozano MD; Castanon E; Baraibar I; Salas D; Hernandez-Lizoain JL; Trocóniz IF; Rodriguez J
PLoS One; 2019; 14(5):e0215970. PubMed ID: 31071108
[TBL] [Abstract][Full Text] [Related]
5. Different strategy of salvage esophagectomy between residual and recurrent esophageal cancer after definitive chemoradiotherapy.
Taniyama Y; Sakurai T; Heishi T; Okamoto H; Sato C; Maruyama S; Onodera Y; Ishida H; Unno M; Kamei T
J Thorac Dis; 2018 Mar; 10(3):1554-1562. PubMed ID: 29707306
[TBL] [Abstract][Full Text] [Related]
6. Factors Predicting Effectiveness of Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Ohkura Y; Ueno M; Iizuka T; Haruta S; Tanaka T; Udagawa H
Medicine (Baltimore); 2016 Apr; 95(15):e3365. PubMed ID: 27082598
[TBL] [Abstract][Full Text] [Related]
7. Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation.
Blank S; Lordick F; Bader F; Burian M; Dobritz M; Grenacher L; Becker K; Weichert W; Langer R; Sisic L; Stange A; Jäger D; Büchler M; Bruckner T; Siewert J; Ott K
Gastric Cancer; 2015 Apr; 18(2):314-25. PubMed ID: 24722800
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy.
Okumura H; Uchikado Y; Matsumoto M; Owaki T; Kita Y; Omoto I; Sasaki K; Sakurai T; Setoyama T; Nabeki B; Matsushita D; Ishigami S; Hiraki Y; Nakajo M; Natsugoe S
Int J Clin Oncol; 2013 Apr; 18(2):329-34. PubMed ID: 22350023
[TBL] [Abstract][Full Text] [Related]
9. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma.
Owaki T; Matsumoto M; Okumura H; Uchicado Y; Kita Y; Setoyama T; Sasaki K; Sakurai T; Omoto I; Shimada M; Sakamoto F; Yoshinaka H; Ishigami S; Ueno S; Natsugoe S
Am J Surg; 2012 Feb; 203(2):191-7. PubMed ID: 21679919
[TBL] [Abstract][Full Text] [Related]
11. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma.
Mallery S; DeCamp M; Bueno R; Mentzer SJ; Sugarbaker DJ; Swanson SJ; Van Dam J
Cancer; 1999 Sep; 86(5):764-9. PubMed ID: 10463973
[TBL] [Abstract][Full Text] [Related]
13. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
Griffin JM; Reed CE; Denlinger CE
Ann Thorac Surg; 2012 Jun; 93(6):1855-9; discussion 1860. PubMed ID: 22516835
[TBL] [Abstract][Full Text] [Related]
14. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
